AbbVie, Inc. (ABBV)
294.45
-0.53
(-0.18%)
USD |
NYSE |
Nov 12, 16:00
295.00
+0.55
(+0.19%)
Pre-Market: 07:42
AbbVie Shareholders Equity (Quarterly) : -4.583B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -4.583B |
| June 30, 2026 | -5.935B |
| March 31, 2026 | -6.656B |
| December 31, 2025 | -3.27B |
| September 30, 2025 | -2.642B |
| June 30, 2025 | -183.00M |
| March 31, 2025 | 1.42B |
| December 31, 2024 | 3.325B |
| September 30, 2024 | 6.032B |
| June 30, 2024 | 6.778B |
| March 31, 2024 | 8.007B |
| December 31, 2023 | 10.36B |
| September 30, 2023 | 12.09B |
| June 30, 2023 | 12.87B |
| March 31, 2023 | 13.27B |
| December 31, 2022 | 17.25B |
| September 30, 2022 | 15.99B |
| June 30, 2022 | 14.65B |
| March 31, 2022 | 16.28B |
| December 31, 2021 | 15.41B |
| September 30, 2021 | 13.55B |
| June 30, 2021 | 12.57B |
| March 31, 2021 | 13.71B |
| December 31, 2020 | 13.08B |
| September 30, 2020 | 15.27B |
| Date | Value |
|---|---|
| June 30, 2020 | 14.71B |
| March 31, 2020 | -7.415B |
| December 31, 2019 | -8.172B |
| September 30, 2019 | -8.226B |
| June 30, 2019 | -8.566B |
| March 31, 2019 | -7.826B |
| December 31, 2018 | -8.446B |
| September 30, 2018 | -2.921B |
| June 30, 2018 | -3.375B |
| March 31, 2018 | 3.553B |
| December 31, 2017 | 5.097B |
| September 30, 2017 | 6.687B |
| June 30, 2017 | 6.009B |
| March 31, 2017 | 4.998B |
| December 31, 2016 | 4.636B |
| September 30, 2016 | 6.469B |
| June 30, 2016 | 5.64B |
| March 31, 2016 | 4.643B |
| December 31, 2015 | 3.945B |
| September 30, 2015 | 4.863B |
| June 30, 2015 | 5.504B |
| March 31, 2015 | 1.377B |
| December 31, 2014 | 1.742B |
| September 30, 2014 | 4.645B |
| June 30, 2014 | 5.218B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.92B |
| Gilead Sciences, Inc. | 13.04B |
| Regeneron Pharmaceuticals, Inc. | 33.50B |
| Amgen, Inc. | 14.35B |
| REGENXBIO, Inc. | 148.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 147.68B |
| Total Liabilities (Quarterly) | 152.22B |
| Debt to Equity Ratio | -17.65 |
| Current Ratio | 0.8696 |
| Net Debt Paydown Yield | -0.45% |